Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
Yi-Long WangWeiqi ChenYi LinXia MengGuohua ChenZhimin WangJialing WuDali WangJianhua LiYibin CaoYuming XuGuohua ZhangXiaobo LiYuesong PanHao LiXingquan ZhaoLiping LiuJinxi LinKehui DongJing JingS Claiborne JohnstonDavid WangYong-Jun Wangnull nullPublished in: BMJ (Clinical research ed.) (2019)
Clinicaltrials.gov NCT02506140.
Keyphrases
- antiplatelet therapy
- open label
- acute coronary syndrome
- study protocol
- percutaneous coronary intervention
- low dose
- atrial fibrillation
- cerebral ischemia
- phase ii
- clinical trial
- phase ii study
- randomized controlled trial
- cardiovascular events
- st segment elevation myocardial infarction
- phase iii
- st elevation myocardial infarction
- coronary artery disease
- placebo controlled
- type diabetes
- blood brain barrier
- rectal cancer